中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 5
May  2021
Turn off MathJax
Article Contents

Value of prognostic nutritional index in predicting the prognosis of patients with hepatic alveolar echinococcosis

DOI: 10.3969/j.issn.1001-5256.2021.05.033
  • Received Date: 2020-10-25
  • Accepted Date: 2020-12-10
  • Published Date: 2021-05-20
  •   Objective  To investigate the value of prognostic nutritional index (PNI) in predicting the prognosis of patients with hepatic alveolar echinococcosis.  Methods  A retrospective analysis was performed for the clinical data of 242 patients who were admitted to Department of Hepatopancreatobiliary Surgery, Qinghai University Affiliated Hospital, from January 2015 to December 2018 and underwent surgical treatment of hepatic alveolar echinococcosis. The results of routine blood test and liver function were collected at 1 week before surgery, and PNI was calculated. X-Tile software was used to determine the cut-off value of PNI, and according to this cut-off value, the patients were divided into high PNI group with 216 patients and low PNI group with 26 patients. The chi-square test was used for comparison of categorical data between groups; the Kaplan-Meier method was used to plot survival curves, and the log-rank test was used for comparison between groups; the Cox regression model was used to perform univariate and multivariate analyses, and hazard ratio (HR) and corresponding 95% confidence interval (CI) were calculated.  Results  PNI was associated with treatment modality, intraoperative blood loss, stage of echinococcosis, number of lesions, Child-Pugh class, aspartate aminotransferase, total bilirubin, albumin, alkaline phosphatase (ALP), prothrombin time (PT), and lymphocyte count (all P < 0.05). The low PNI group had 1-, 3-, and 5-year survival rates of 92.1%, 30.5%, and 20.3%, respectively, after surgery, while the high PNI group had 1-, 3-, and 5-year survival rates of 95.7%, 79.5%, and 56.9%, respectively. The mean survival time was 33.783 (95% CI: 26.450-51.355) months in the low PNI group and 51.355 (95% CI: 49.044-53.666) months in the high PNI group, and there was a significant difference between the two groups (χ2=24.626, P < 0.001). The univariate Cox regression analysis showed that PNI, surgical procedure, intraoperative blood loss, stage of echinococcosis, Child-Pugh class, complication, ALP, PT, neutrophils, and platelets were associated with the prognosis of patients with hepatic alveolar echinococcosis (all P < 0.05), and the multivariate Cox regression analysis showed that treatment modality (HR=1.461, 95%CI: 1.132-1.890, P=0.004), intraoperative blood loss (HR=6.078, 95%CI: 3.412-10.826, P < 0.001), PNI(HR=0.367, 95%CI: 0.192-0.701, P=0.002), complications (HR=2.007, 95%CI: 1.204-3.346, P=0.008), and neutrophils (HR=2.772, 95%CI: 1.304-5.891, P=0.008) were independent risk factors for the prognosis of patients with hepatic alveolar echinococcosis.  Conclusion  PNI can be used to predict the prognosis of patients with hepatic alveolar echinococcosis. The higher the peripheral blood PNI before surgery, the better the prognosis of patients.

     

  • loading
  • [1]
    WANG WT, YANG C, YAN LN. New concept and strategy of surgical radical treatment of hepatic alveolar echinococcosis[J]. Natl Med J China, 2018, 98(38): 3049-3051. DOI: 10.3760/cma.j.issn.0376-2491.2018.38.001.

    王文涛, 杨闯, 严律南. 肝泡型包虫病外科根治性治疗的新理念与策略[J]. 中华医学杂志, 2018, 98(38): 3049-3051. DOI: 10.3760/cma.j.issn.0376-2491.2018.38.001.
    [2]
    NABULAJIANG A, TUERGANAILI A. Current status of research on laparoscopic treatment of hepatic cystic echinococcosis[J]. J Clin Hepatol, 2020, 36(11): 2613-2616. DOI: 10.3969/j.issn.1001-5256.2020.11.049.

    那布拉江·艾合买提, 吐尔干艾力·阿吉. 腹腔镜治疗肝囊型包虫病的研究现状[J]. 临床肝胆病杂志, 2020, 36(11): 2613-2616. DOI: 10.3969/j.issn.1001-5256.2020.11.049.
    [3]
    Chinese Doctor Association, Chinese College of Surgeons(CCS), Chinese Committee for Hadytidology(CCH). Expert consensus on diagnosis and treatment of hepatic cystic and alveolar echinococcosis (2019 edition)[J]. Chin J Dig Surg, 2019, 18(8): 711-721. DOI: 10.3760/cma.j.issn.1673-9752.2019.08.002.

    中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8): 711-721. DOI: 10.3760/cma.j.issn.1673-9752.2019.08.002.
    [4]
    BUZBY GP, MULLEN JL, MATTHEWS DC, et al. Prognostic nutritional index in gastrointestinal surgery[J]. Am J Surg, 1980, 139(1): 160-167. DOI: 10.1016/0002-9610(80)90246-9.
    [5]
    SCHWEGLER I, von HOLZEN A, GUTZWILLER JP, et al. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer[J]. Br J Surg, 2010, 97(1): 92-97. DOI: 10.1002/bjs.6805.
    [6]
    KWAG SJ, KIM JG, KANG WK, et al. The nutritional risk is a independent factor for postoperative morbidity in surgery for colorectal cancer[J]. Ann Surg Treat Res, 2014, 86(4): 206-211. DOI: 10.4174/astr.2014.86.4.206.
    [7]
    STOTZ M, PICHLER M, ABSENGER G, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage Ⅲ colon cancer[J]. Br J Cancer, 2014, 110(2): 435-440. DOI: 10.1038/bjc.2013.785.
    [8]
    ONODERA T, GOSEKI N, KOSAKI G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients[J]. Nihon Geka Gakkai Zasshi, 1984, 85(9): 1001-1005.
    [9]
    HU WH, EISENSTEIN S, PARRY L, et al. Preoperative malnutrition with mild hypoalbuminemia associated with postoperative mortality and morbidity of colorectal cancer: A propensity score matching study[J]. Nutr J, 2019, 18(1): 33. DOI: 10.1186/s12937-019-0458-y.
    [10]
    CAMP RL, DOLLED-FILHART M, RIMM DL. X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization[J]. Clin Cancer Res, 2004, 10(21): 7252-7259. DOI: 10.1158/1078-0432.CCR-04-0713.
    [11]
    PASTORE CA, ORLANDI SP, GONZALEZ MC. The Inflammatory-Nutritional Index; assessing nutritional status and prognosis in gastrointestinal and lung cancer patients[J]. Nutr Hosp, 2014, 29--(3): 629-634. DOI: 10.3305/nh.2014.29.3.7195.
    [12]
    SONG SB, LIU HG, XUE YW. Clinical significance of prognostic nutritional index in patients with advanced gastric cancer[J]. Chin J Gastrointestinal Surg, 2018, 21(2): 180-184. DOI: 10.3760/cma.j.issn.1671-0274.2018.02.012.

    宋书彬, 刘宏刚, 薛英威. 进展期胃癌患者预后营养指数的临床意义[J]. 中华胃肠外科杂志, 2018, 21(2): 180-184. DOI: 10.3760/cma.j.issn.1671-0274.2018.02.012.
    [13]
    ZHANG GL, LUO JG, SUN YS, et al. The relationship between the expression of ubiquitin in muscle tissue of patients with gastric cancer and nutritional status and prognosis[J]. Chin J Clin Nutrition, 2018, 26(2): 78-82. DOI: 10.3760/cma.j.issn.1674-635X.2018.02.003.

    章国良, 罗钧刚, 孙元水, 等. 胃癌患者肌肉组织中泛素表达与营养状况和预后的关系[J]. 中华临床营养杂志, 2018, 26(2): 78-82. DOI: 10.3760/cma.j.issn.1674-635X.2018.02.003.
    [14]
    FLAVILL E, FANG YV, MILES B, et al. Induction chemotherapy followed by concurrent chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma with HPV and P16 testing[J]. Ann Otol Rhinol Laryngol, 2014, 123(5): 365-373. DOI: 10.1177/0003489414526685.
    [15]
    PINATO DJ, NORTH BV, SHARMA R. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: The prognostic nutritional index (PNI)[J]. Br J Cancer, 2012, 106(8): 1439-1445. DOI: 10.1038/bjc.2012.92.
    [16]
    MOHRI Y, INOUE Y, TANAKA K, et al. Prognostic nutritional index predicts postoperative outcome in colorectal cancer[J]. World J Surg, 2013, 37(11): 2688-2692. DOI: 10.1007/s00268-013-2156-9.
    [17]
    WU JW, YU XJ, YANG QA. Association between Onodera's prognostic nutrition index and adverse effects of concurrent chemoradiotherapy for esophageal squamous cell carcinoma[J]. China Oncology, 2020, 30(7): 525-530. DOI: 10.19401/j.cnki.1007-3639.2020.07.007.

    吴婧文, 于学娟, 杨秋安. 小野寺预后营养指数与食管鳞癌同步放化疗不良反应的相关性研究[J]. 中国癌症杂志, 2020, 30(7): 525-530. DOI: 10.19401/j.cnki.1007-3639.2020.07.007.
    [18]
    YANG XJ, SHEN H, YUAN W, et al. Effect of supplemental parenteral nutrition on the pre-operative system immune inflammation index and postoperative prognostic nutrition index in esophageal cancer[J]. J Clin Exp Med, 2020, 19(20): 2202-2205. DOI: 10.3969/j.issn.1671-4695.2020.20.022.

    杨小娟, 沈慧, 袁伟, 等. 补充性肠外营养对食管癌术前系统免疫炎症指数及术后预后营养指数的影响[J]. 临床和实验医学杂志, 2020, 19(20): 2202-2205. DOI: 10.3969/j.issn.1671-4695.2020.20.022.
    [19]
    MANTZOROU M, KOUTELIDAKIS A, THEOCHARIS S, et al. Clinical value of nutritional status in cancer: What is its impact and how it affects disease progression and prognosis?[J]. Nutr Cancer, 2017, 69(8): 1151-1176. DOI: 10.1080/01635581.2017.1367947.
    [20]
    SHAO J, WANG ZX, WANG H, et al. Antibody microarray analysis of the serum inflammatory cytokines in patients with hepatic alveolar echinococcosis[J]. Chin J Gastroenterol Hepatol, 2017, 26(5): 566-569. DOI: 10.3969/j.issn.1006-5709.2017.05.024.

    邵军, 王志鑫, 王虎, 等. 泡型肝包虫病患者血清炎症因子的抗体芯片检测及分析[J]. 胃肠病学和肝病学杂志, 2017, 26(5): 566-569. DOI: 10.3969/j.issn.1006-5709.2017.05.024.
    [21]
    ZHANG F, PANG N, ZHU Y, et al. CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells are positively correlated with levels of IL-21 in active and transitional cystic echinococcosis patients[J]. BMC Infect Dis, 2015, 15: 457. DOI: 10.1186/s12879-015-1156-9.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Article Metrics

    Article views (390) PDF downloads(19) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return